Guidance in topic selection
Showing 11 to 13 of 13
Title | Technology type | Decision | Decision date |
---|---|---|---|
Dupilumab for maintenance treatment of uncontrolled moderate to severe asthma in children 6 to 11 years [TS ID 10085] | Medicine | Not selected | |
Moor LDLS-BI for assessing burn depth and healing potential in children and adults | Device | Not selected | |
Fingolimod for treating relapsing multiple sclerosis in children and young people [ID1378] | Medicine | Not selected |